CN102526514A - Medicine used for treating allergic purpura - Google Patents
Medicine used for treating allergic purpura Download PDFInfo
- Publication number
- CN102526514A CN102526514A CN2011103714885A CN201110371488A CN102526514A CN 102526514 A CN102526514 A CN 102526514A CN 2011103714885 A CN2011103714885 A CN 2011103714885A CN 201110371488 A CN201110371488 A CN 201110371488A CN 102526514 A CN102526514 A CN 102526514A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- grams
- medicine
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine used for treating allergic purpura. Medicines, such as astragalus mongholicus, ginseng, rhizoma atractylodis macrocephalae, angelica sinensis, radix rehmanniae, the root of red-rooted salvia, cortex moutan, scutellaria baicalensis, schisandra chinensis, smoked plum, hairyvein agrimony, lithospermum, rhizoma imperatae, eclipta alba, caulis spatholobi, madder and divaricate saposhnikovia root are smashed into powder, and then the powder is prepared into powder preparation to be orally taken. The medicine disclosed by the invention has the efficacy on tonifying spleen, tonifying qi, clearing heat, cooling blood, promoting circulation and removing stasis, and has the advantages of high cure rate for treating the allergic purpura, low recurrence rate, small toxic and side effect and no harm to liver or kidney, and the total effective rate is 99% by clinic observation.
Description
Technical field:
The present invention relates to a kind of medicine of treating anaphylactoid purpura, particularly relating to a kind of is the Chinese medicine of the treatment anaphylactoid purpura of feedstock production with Chinese medicine.
Background technology:
Along with the physics and chemistry industrial boom, environmental pollution increases the weight of day by day, and people health in serious harm.Anaphylactoid purpura changes present commonly encountered diseases, frequently-occurring disease into by original rare disease, and is the gesture of rising year by year in recent years, and any age all can fall ill, but sees with the child more.Its main cause is: fast pace life now makes the damage of human body vigour, adds environmental pollution, food pollution.
Integrative therapy should disease all be faced with some problems both at home and abroad at present, mainly was take effect slow, high, the weak curative effect of relapse rate.So want to improve cure rate, reduce relapse rate, key is to use traditional Chinese medical science treating both the principal and secondary aspects of a disease, improves cure rate, reduces relapse rate.
Summary of the invention:
The purpose of this invention is to provide a kind of medicine that is used to treat anaphylactoid purpura, this medicine spleen invigorating, QI invigorating, heat clearing away, removing heat from blood, blood circulation promoting and blood stasis dispelling.Be used to treat that the anaphylactoid purpura cure rate is high, relapse rate is low, have no side effect.
Medicine of the present invention is that feedstock production obtains by following parts by weight of traditional Chinese medicines:
The Radix Astragali 300 gram Radix Ginseng Rubra 100 gram Rhizoma Atractylodis Macrocephalaes 150 gram Radix Angelicae Sinensis 150 gram Radix Rehmanniae 300 gram Radix Salviae Miltiorrhizaes 300 gram Cortex Moutans 150 grams
Skullcap 300 grams? Schisandra 100 grams? Ebony 100 grams? Agrimony 300 grams? Comfrey 300 grams? White acorns root 300 g
Windproof 150 grams of western Radix Rubiae 100 grams of Herba Ecliptae 300 gram Caulis Spatholobis 300 grams.
Said medicine is pulverized sieve 150-200 purpose powder behind the mix homogeneously, and it is subsequent use to process powder, and per 10 grams are divided into a bag, each bag, and every day 3 times, 15 is a course of treatment.
In whole prescription, Radix Astragali spleen invigorating QI invigorating is mended three warmers and is opened the real gas of defending, in current the going up down, inside and outside three warmers; The Radix Ginseng Rubra strongly invigorating primordial QI; The Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis assistance Radix Astragali dampness and blood, spleen invigorating; Radix Scutellariae can be regulated cAMP and allergy, can reduce antigen and combine with IgE, suppresses mastocyte and discharges histamine, alleviates allergy; Windproof, Fructus Mume can stimulate through non-characteristic makes body produce in the more free antibodies and anaphylactogen; The Herba Agrimoniae and the Radix Rehmanniae, Cortex Moutan, Radix Salviae Miltiorrhizae, Radix Arnebiae (Radix Lithospermi) compatibility play removing heat from blood, invigorate blood circulation, stop blooding and do not stay the stasis of blood.The kind again branch pyretic toxicity that purifies the blood of Radix Arnebiae (Radix Lithospermi), this is sick biased in nutrient blood, " goes into blood with regard to the moving blood of hematozemia, directly palpus removing pathogenic heat from blood and dissipating blood stasis by Ye Tianshi." our combination and compatibility is appropriate, can QI invigorating, spleen invigorating makes blood return spleen, again can clearing away heat and cooling blood, invigorate blood circulation.Have replenishing QI to invigorate the spleen and the accent Wei Zhigong of battalion, can reach the purpose of healing.
Medicine instant effect of the present invention, good effect has no side effect.Generally take and to heal entirely 2~3 courses of treatment.Anaphylactoid purpura there is better curative effect.
Be the further clinical efficacy and the safety of proof medicine of the present invention.Select 300 routine patients with anaphylactoid purpura that medicine of the present invention is carried out clinical observation.
Among the 300 routine patients, child patient 178 examples, young patient's 122 examples.All use the present invention to treat, take every day three times.
Criterion of therapeutical effect: produce effects: red rash disappears, and ecchymosis disappears, and does not have new erythra to occur again; Effectively: red rash disappears, and occurs 1~2 little erythra once in a while, disappears again after the rest; Invalid: as to disappear though erythra and ecchymosis have, but have new erythra and ecchymosis constantly to occur.
Table 1 treatment back curative effect statistical result
The patient | The example number | Produce effects (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
Child patient | 178 | 124(69.7) | 52(29.2) | 2(1.1) | 176(98.9) |
Young patient | 122 | 93(76.2) | 28(23.0) | 1(0.8) | 121(99.2) |
Amount to | 300 | 217(72.3) | 80(26.7) | 3(1.0) | 297(99) |
The specific embodiment:
Windproof 150 grams of the Radix Astragali 300 gram Radix Ginseng Rubra 100 gram Rhizoma Atractylodis Macrocephalaes, 150 gram Radix Angelicae Sinensis, the 150 gram Radix Rehmanniae, 300 gram Radix Salviae Miltiorrhizaes, 300 gram Cortex Moutans, 150 gram Radix Scutellariaes, 300 gram Fructus Schisandrae Chinensis, 100 gram Fructus Mumes, 100 gram Herba Agrimoniaes, 300 gram Radix Arnebiae (Radix Lithospermi)s, 300 gram Rhizoma Imperataes, 300 gram Herba Ecliptaes western Radix Rubiae 100 grams of 300 gram Caulis Spatholobis, 300 grams.
Said medicine is pulverized sieve 150-200 purpose powder behind the mix homogeneously, process powder, 10 grams are a bag, and each bag, is generally taken 2~3 courses of treatment and can be obtained recovery from illness at every day 3 times.
Claims (3)
1. medicine that is used to treat anaphylactoid purpura is that feedstock production obtains by the Chinese medicine of following portions by weight:
The Radix Astragali 300 gram Radix Ginseng Rubra 100 gram Rhizoma Atractylodis Macrocephalaes 150 gram Radix Angelicae Sinensis 150 gram Radix Rehmanniae 300 gram Radix Salviae Miltiorrhizaes 300 gram Cortex Moutans 150 grams
Radix Scutellariae 300 gram Fructus Schisandrae Chinensis 100 gram Fructus Mumes 100 gram Herba Agrimoniaes 300 gram Radix Arnebiae (Radix Lithospermi)s 300 gram Rhizoma Imperataes 300 grams
Windproof 150 grams of western Radix Rubiae 100 grams of Herba Ecliptae 300 gram Caulis Spatholobis 300 grams.
2. a kind of medicine that is used to treat anaphylactoid purpura according to claim 1 is characterized in that described medicine is pulverized mix homogeneously sieve 150~200 purpose powder, and it is subsequent use to process powder.
3. a kind of medicine that is used to treat anaphylactoid purpura according to claim 1, its instructions of taking are with above-mentioned smalls and even, and per 10 grams are a parcel, each bag, and 15 is a course of treatment, 2---can obtain recovery from illness 3 courses of treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110371488.5A CN102526514B (en) | 2011-11-12 | 2011-11-12 | Medicine used for treating allergic purpura |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110371488.5A CN102526514B (en) | 2011-11-12 | 2011-11-12 | Medicine used for treating allergic purpura |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526514A true CN102526514A (en) | 2012-07-04 |
CN102526514B CN102526514B (en) | 2014-02-05 |
Family
ID=46335334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110371488.5A Active CN102526514B (en) | 2011-11-12 | 2011-11-12 | Medicine used for treating allergic purpura |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526514B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103948830A (en) * | 2014-05-09 | 2014-07-30 | 魏耀虎 | Drug for treating purpura |
CN104042970A (en) * | 2014-07-06 | 2014-09-17 | 华菊 | Traditional Chinese medicine (TCM) composition for allergic purpura |
CN104740414A (en) * | 2015-04-21 | 2015-07-01 | 王雪雁 | Traditional Chinese medicine preparation for treating anaphylactoid purpura and preparation technology of traditional Chinese medicine preparation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574511A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine composition for curing purpura |
CN101574474A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine composition for curing purpura |
CN101623383A (en) * | 2008-07-08 | 2010-01-13 | 吴彦勇 | Chinese medicinal composition for treating allergic purpura |
CN101658643A (en) * | 2009-09-15 | 2010-03-03 | 刘锋 | Medicament for treating allergic purpura |
CN101972351A (en) * | 2010-09-27 | 2011-02-16 | 陈树亮 | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
-
2011
- 2011-11-12 CN CN201110371488.5A patent/CN102526514B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101623383A (en) * | 2008-07-08 | 2010-01-13 | 吴彦勇 | Chinese medicinal composition for treating allergic purpura |
CN101574511A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine composition for curing purpura |
CN101574474A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine composition for curing purpura |
CN101658643A (en) * | 2009-09-15 | 2010-03-03 | 刘锋 | Medicament for treating allergic purpura |
CN101972351A (en) * | 2010-09-27 | 2011-02-16 | 陈树亮 | Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103948830A (en) * | 2014-05-09 | 2014-07-30 | 魏耀虎 | Drug for treating purpura |
CN104042970A (en) * | 2014-07-06 | 2014-09-17 | 华菊 | Traditional Chinese medicine (TCM) composition for allergic purpura |
CN104740414A (en) * | 2015-04-21 | 2015-07-01 | 王雪雁 | Traditional Chinese medicine preparation for treating anaphylactoid purpura and preparation technology of traditional Chinese medicine preparation |
Also Published As
Publication number | Publication date |
---|---|
CN102526514B (en) | 2014-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
CN102940721B (en) | Medicine for treating chronic pelvic inflammation | |
CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
CN103800827A (en) | Traditional Chinese medicine for treating liver cancer | |
CN103655989A (en) | Traditional Chinese medicine for external use for treating rheumatic arthritis | |
CN102526514B (en) | Medicine used for treating allergic purpura | |
CN103285334B (en) | Prescription for treatment of depressive neurosis | |
CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
CN103272136B (en) | Traditional Chinese medicine for treating climacteric syndrome of women | |
CN103239656B (en) | Traditional Chinese medicine for treating psoriasis | |
CN103301328B (en) | Trigeminal neuralgia treatment medicine | |
CN102698214B (en) | Traditional Chinese medicine for treating migraine and preparation method thereof | |
CN102451427A (en) | Heart nursing pellets | |
CN102038751A (en) | Traditional Chinese medicine formulation for treating infantile diarrhea | |
CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
CN103690824A (en) | A traditional Chinese medicine used for treating dermatomyositis | |
CN103272159A (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
CN102836347B (en) | Traditional Chinese medicine for treating tinnitus | |
CN102078432A (en) | Medicament for treating skin itch | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN103784689A (en) | Medicinal composition for treating leukemia | |
CN103800456A (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN103656149A (en) | Preparation method of traditional Chinese medicine prescription for treating insomnia | |
CN105079399A (en) | Traditional Chinese medicine ointment for treating skin itch and preparation method of traditional Chinese medicine ointment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 037600 science and Technology Bureau of South Third Ring Road, Yingxian County New South Road, Shuozhou, Shanxi Patentee after: Zhao Zeng Address before: 036002 Shanxi city of Shuozhou province shuochengqu Water Street (Yanmen Street) the first section of No. 8 Patentee before: Zhao Zeng |